Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
Phase 3
Not yet recruiting
- Conditions
- Pregnancy Related
- Registration Number
- NCT06069869
- Lead Sponsor
- George Washington University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria:<br><br> - Attending first ANC visit at the study clinic<br><br> - Pregnant women = 15 weeks of gestation<br><br> - Aged = 18 years<br><br> - Intending to stay in Dar es Salaam for the duration of study<br><br> - Provides informed consent<br><br>Exclusion Criteria:<br><br> - Severe anemia (defined as Hb <8.5 g/dL per Tanzania standard of care)<br><br> - Sickle cell disease (SS and SC) and hemoglobin C disease (CC) as tested by<br> HemoTypeSC<br><br> - Concurrent participation in other nutritional supplementation trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acceptability of MMS formulations
- Secondary Outcome Measures
Name Time Method Most preferred MMS formulation;Side effects of MMS formulations;Adherence